Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 10 of 10 entries
Sorted by: Best Match Show Resources per page
Carcinoma of the esophagus: Is there a role for surgery? The case against surgery.

The American journal of digestive diseases

Moertel CG.
PMID: 685942
Am J Dig Dis. 1978 Aug;23(8):735-6. doi: 10.1007/BF01072363.

No abstract available.

Cite
Moertel CG. Carcinoma of the esophagus: Is there a role for surgery? The case against surgery. Am J Dig Dis. 1978;23(8):735-6doi: 10.1007/BF01072363.
Moertel, C. G. (1978). Carcinoma of the esophagus: Is there a role for surgery? The case against surgery. The American journal of digestive diseases, 23(8), 735-6. https://doi.org/10.1007/BF01072363
Moertel, C G. "Carcinoma of the esophagus: Is there a role for surgery? The case against surgery." The American journal of digestive diseases vol. 23,8 (1978): 735-6. doi: https://doi.org/10.1007/BF01072363
Moertel CG. Carcinoma of the esophagus: Is there a role for surgery? The case against surgery. Am J Dig Dis. 1978 Aug;23(8):735-6. doi: 10.1007/BF01072363. PMID: 685942.
Copy Download .nbib Format: NLM
Cancer of the oesophagus.

BMJ (Clinical research ed.)

Bancewicz J.
PMID: 1688726
BMJ. 1990 Jan 06;300(6716):3-4. doi: 10.1136/bmj.300.6716.3.
Free PMC Article

No abstract available.

Cite
Bancewicz J. Cancer of the oesophagus. BMJ. 1990;300(6716):3-4doi: 10.1136/bmj.300.6716.3.
Bancewicz, J. (1990). Cancer of the oesophagus. BMJ (Clinical research ed.), 300(6716), 3-4. https://doi.org/10.1136/bmj.300.6716.3
Bancewicz, J. "Cancer of the oesophagus." BMJ (Clinical research ed.) vol. 300,6716 (1990): 3-4. doi: https://doi.org/10.1136/bmj.300.6716.3
Bancewicz J. Cancer of the oesophagus. BMJ. 1990 Jan 06;300(6716):3-4. doi: 10.1136/bmj.300.6716.3. PMID: 1688726; PMCID: PMC1661882.
Copy Download .nbib Format: NLM
[Personal experience with the surgical treatment of esophageal carcinoma].

Casopis lekaru ceskych

Pesková M, Klofanda J, Schmidt D, Hrubý M.
PMID: 2428499
Cas Lek Cesk. 1986 Sep 05;125(36):1132-4.

No abstract available.

Cite
Pesková M, Klofanda J, Schmidt D, et al. Nase zkusenosti s chirurgickou lécbou karcinomu jícnu. [Personal experience with the surgical treatment of esophageal carcinoma]. Cas Lek Cesk. 1986;125(36):1132-4
Pesková, M., Klofanda, J., Schmidt, D., & Hrubý, M. (1986). Nase zkusenosti s chirurgickou lécbou karcinomu jícnu. [Personal experience with the surgical treatment of esophageal carcinoma]. Casopis lekaru ceskych, 125(36), 1132-4.
Pesková, M, et al. "Nase zkusenosti s chirurgickou lécbou karcinomu jícnu." [Personal experience with the surgical treatment of esophageal carcinoma]. Casopis lekaru ceskych vol. 125,36 (1986): 1132-4.
Pesková M, Klofanda J, Schmidt D, Hrubý M. Nase zkusenosti s chirurgickou lécbou karcinomu jícnu. [Personal experience with the surgical treatment of esophageal carcinoma]. Cas Lek Cesk. 1986 Sep 05;125(36):1132-4. Czech. PMID: 2428499.
Copy Download .nbib Format: NLM
Circumferential resection margin in esophageal cancer.

Journal of the Chinese Medical Association : JCMA

Hsu HS.
PMID: 23880576
J Chin Med Assoc. 2013 Oct;76(10):537-8. doi: 10.1016/j.jcma.2013.06.008. Epub 2013 Jul 20.

No abstract available.

Cite
Hsu HS. Circumferential resection margin in esophageal cancer. J Chin Med Assoc. 2013;76(10):537-8doi: 10.1016/j.jcma.2013.06.008.
Hsu, H. S. (2013). Circumferential resection margin in esophageal cancer. Journal of the Chinese Medical Association : JCMA, 76(10), 537-8. https://doi.org/10.1016/j.jcma.2013.06.008
Hsu, Han-Shui. "Circumferential resection margin in esophageal cancer." Journal of the Chinese Medical Association : JCMA vol. 76,10 (2013): 537-8. doi: https://doi.org/10.1016/j.jcma.2013.06.008
Hsu HS. Circumferential resection margin in esophageal cancer. J Chin Med Assoc. 2013 Oct;76(10):537-8. doi: 10.1016/j.jcma.2013.06.008. Epub 2013 Jul 20. PMID: 23880576.
Copy Download .nbib Format: NLM
Management of oesophageal cancer.

BMJ (Clinical research ed.)

Weil JG, Munday SJ.
PMID: 8173441
BMJ. 1994 Apr 23;308(6936):1103. doi: 10.1136/bmj.308.6936.1103b.
Free PMC Article

No abstract available.

Cite
Weil JG, Munday SJ. Management of oesophageal cancer. BMJ. 1994;308(6936):1103doi: 10.1136/bmj.308.6936.1103b.
Weil, J. G., & Munday, S. J. (1994). Management of oesophageal cancer. BMJ (Clinical research ed.), 308(6936), 1103. https://doi.org/10.1136/bmj.308.6936.1103b
Weil, J G, and Munday, S J. "Management of oesophageal cancer." BMJ (Clinical research ed.) vol. 308,6936 (1994): 1103. doi: https://doi.org/10.1136/bmj.308.6936.1103b
Weil JG, Munday SJ. Management of oesophageal cancer. BMJ. 1994 Apr 23;308(6936):1103. doi: 10.1136/bmj.308.6936.1103b. PMID: 8173441; PMCID: PMC2539972.
Copy Download .nbib Format: NLM
[Esophageal cancer. 3. Surgery and follow-up studies of esophageal cancer].

Kyobu geka. The Japanese journal of thoracic surgery

Sato H, Nabeya K, Nakano K, Makino K, Isono K.
PMID: 5750409
Kyobu Geka. 1968 Jul;21(7):478-84.

No abstract available.

Cite
Sato H, Nabeya K, Nakano K, et al. [Esophageal cancer. 3. Surgery and follow-up studies of esophageal cancer]. Kyobu Geka. 1968;21(7):478-84
Sato, H., Nabeya, K., Nakano, K., Makino, K., & Isono, K. (1968). [Esophageal cancer. 3. Surgery and follow-up studies of esophageal cancer]. Kyobu geka. The Japanese journal of thoracic surgery, 21(7), 478-84.
Sato, H, et al. "[Esophageal cancer. 3. Surgery and follow-up studies of esophageal cancer]." Kyobu geka. The Japanese journal of thoracic surgery vol. 21,7 (1968): 478-84.
Sato H, Nabeya K, Nakano K, Makino K, Isono K. [Esophageal cancer. 3. Surgery and follow-up studies of esophageal cancer]. Kyobu Geka. 1968 Jul;21(7):478-84. Japanese. PMID: 5750409.
Copy Download .nbib Format: NLM
Reply to: Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))

Doulami G, Theodorou D.
PMID: 21798730
Clin Oncol (R Coll Radiol). 2011 Nov;23(9):653; author reply 653. doi: 10.1016/j.clon.2011.07.004. Epub 2011 Jul 28.

No abstract available.

Cite
Doulami G, Theodorou D. Reply to: Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol (R Coll Radiol). 2011;23(9):653; author reply 653doi: 10.1016/j.clon.2011.07.004.
Doulami, G., & Theodorou, D. (2011). Reply to: Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. Clinical oncology (Royal College of Radiologists (Great Britain)), 23(9), 653; author reply 653. https://doi.org/10.1016/j.clon.2011.07.004
Doulami, G, and Theodorou, D. "Reply to: Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer." Clinical oncology (Royal College of Radiologists (Great Britain)) vol. 23,9 (2011): 653; author reply 653. doi: https://doi.org/10.1016/j.clon.2011.07.004
Doulami G, Theodorou D. Reply to: Definitive chemoradiation for oesophageal cancer--a standard of care in patients with non-metastatic oesophageal cancer. Clin Oncol (R Coll Radiol). 2011 Nov;23(9):653; author reply 653. doi: 10.1016/j.clon.2011.07.004. Epub 2011 Jul 28. PMID: 21798730.
Copy Download .nbib Format: NLM
Double indemnity in oesophageal carcinoma?.

British medical journal (Clinical research ed.)

McKeown KC.
PMID: 6404462
Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1357. doi: 10.1136/bmj.286.6374.1357-a.
Free PMC Article

No abstract available.

Cite
McKeown KC. Double indemnity in oesophageal carcinoma?. Br Med J (Clin Res Ed). 1983;286(6374):1357doi: 10.1136/bmj.286.6374.1357-a.
McKeown, K. C. (1983). Double indemnity in oesophageal carcinoma?. British medical journal (Clinical research ed.), 286(6374), 1357. https://doi.org/10.1136/bmj.286.6374.1357-a
McKeown, K C. "Double indemnity in oesophageal carcinoma?." British medical journal (Clinical research ed.) vol. 286,6374 (1983): 1357. doi: https://doi.org/10.1136/bmj.286.6374.1357-a
McKeown KC. Double indemnity in oesophageal carcinoma?. Br Med J (Clin Res Ed). 1983 Apr 23;286(6374):1357. doi: 10.1136/bmj.286.6374.1357-a. PMID: 6404462; PMCID: PMC1547595.
Copy Download .nbib Format: NLM
Emerging Multimodality Approaches to Treat Localized Esophageal Cancer.

Journal of the National Comprehensive Cancer Network : JNCCN

Kelly RJ.
PMID: 31390584
J Natl Compr Canc Netw. 2019 Aug 01;17(8):1009-1014. doi: 10.6004/jnccn.2019.7337.

Esophageal cancer has a poor prognosis, with 5-year survival rates ranging from 20% to 35% in the nonmetastatic setting. Despite advances in surgical techniques and optimization of chemoradiotherapy regimens, overall survival benefits have been incremental at best. Esophageal cancer...

Cite
Kelly RJ. Emerging Multimodality Approaches to Treat Localized Esophageal Cancer. J Natl Compr Canc Netw. 2019;17(8):1009-1014doi: 10.6004/jnccn.2019.7337.
Kelly, R. J. (2019). Emerging Multimodality Approaches to Treat Localized Esophageal Cancer. Journal of the National Comprehensive Cancer Network : JNCCN, 17(8), 1009-1014. https://doi.org/10.6004/jnccn.2019.7337
Kelly, Ronan J. "Emerging Multimodality Approaches to Treat Localized Esophageal Cancer." Journal of the National Comprehensive Cancer Network : JNCCN vol. 17,8 (2019): 1009-1014. doi: https://doi.org/10.6004/jnccn.2019.7337
Kelly RJ. Emerging Multimodality Approaches to Treat Localized Esophageal Cancer. J Natl Compr Canc Netw. 2019 Aug 01;17(8):1009-1014. doi: 10.6004/jnccn.2019.7337. PMID: 31390584.
Copy Download .nbib Format: NLM
[Comprehensive therapeutic strategy for localized esophageal cancer. Second part : interest of multimodal approaches with or without surgery].

Revue medicale de Liege

Van Daele D, Honoré P, Collignon J, Polus M, Loly C, Mutijima E, De Roover A, Coucke PA, Louis E, Martinive P.
PMID: 28471547
Rev Med Liege. 2017 Apr;72(4):168-174.

In recent years, the treatment of esophagus cancer has been completely changed, thus competing the dogma of surgery as the cornerstone treatment. Multimodality treatments as radio-chemotherapy directly followed by surgery, or delayed surgery, significantly improve patient survival compared to...

Cite
Van Daele D, Honoré P, Collignon J, et al. Comment je traite... les cancers localisés de l’œsophage. Etat actuel des données et stratégie thérapeutique. 2ème partie : l’intérêt des approches multimodales avec ou sans chirurgie. [Comprehensive therapeutic strategy for localized esophageal cancer. Second part : interest of multimodal approaches with or without surgery]. Rev Med Liege. 2017;72(4):168-174
Van Daele, D., Honoré, P., Collignon, J., Polus, M., Loly, C., Mutijima, E., De Roover, A., Coucke, P. A., Louis, E., & Martinive, P. (2017). Comment je traite... les cancers localisés de l’œsophage. Etat actuel des données et stratégie thérapeutique. 2ème partie : l’intérêt des approches multimodales avec ou sans chirurgie. [Comprehensive therapeutic strategy for localized esophageal cancer. Second part : interest of multimodal approaches with or without surgery]. Revue medicale de Liege, 72(4), 168-174.
Van Daele, D, et al. "Comment je traite... les cancers localisés de l’œsophage. Etat actuel des données et stratégie thérapeutique. 2ème partie : l’intérêt des approches multimodales avec ou sans chirurgie." [Comprehensive therapeutic strategy for localized esophageal cancer. Second part : interest of multimodal approaches with or without surgery]. Revue medicale de Liege vol. 72,4 (2017): 168-174.
Van Daele D, Honoré P, Collignon J, Polus M, Loly C, Mutijima E, De Roover A, Coucke PA, Louis E, Martinive P. Comment je traite... les cancers localisés de l’œsophage. Etat actuel des données et stratégie thérapeutique. 2ème partie : l’intérêt des approches multimodales avec ou sans chirurgie. [Comprehensive therapeutic strategy for localized esophageal cancer. Second part : interest of multimodal approaches with or without surgery]. Rev Med Liege. 2017 Apr;72(4):168-174. French. PMID: 28471547.
Copy Download .nbib Format: NLM
Showing 1 to 10 of 10 entries